<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0907245509
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1998
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        HUMALOG 100 I.U VIALS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        INSULIN LISPRO
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        IU/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Subcutaneous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        89.80
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ELI LILLY" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ELI LILLY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Eli Lilly and Company
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A10AB04
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Humalog is used to treat diabetes. Humalog works more quickly than normal human insulin because the insulin molecule has been changed slightly.</p><p>You get diabetes if your pancreas does not make enough insulin to control the level of glucose in your blood. Humalog is a substitute for your own insulin and is used to control glucose in the long term. It works very quickly and lasts a shorter time than soluble insulin (2 to 5 hours). You should normally use Humalog within 15 minutes of a meal.</p><p>Your doctor may tell you to use Humalog as well as a longer-acting insulin. Each kind of insulin comes with another patient information leaflet to tell you about it. Do not change your insulin unless your doctor tells you to. Be very careful if you do change insulin.</p><p>Humalog is suitable for use in adults and children.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do NOT use Humalog</strong></p><ul><li>if you think <strong>hypoglycaemia</strong> (low blood sugar) is starting. Further in this leaflet it tells you how to deal with mild hypoglycaemia (see Section 3: If you use more Humalog than you should).</li><li>if you are <strong>allergic</strong> &nbsp;to insulin lispro or any of the other ingredients of this medicine (listed in section 6).</li></ul><p><strong>Warnings and precautions </strong></p><ul><li>Always check the pack and the vial label for the name and type of the insulin when you get it from your pharmacy. Make sure you get the Humalog that your doctor has told you to use.</li><li>If your blood sugar levels are well controlled by your current insulin therapy, you may not feel the warning symptoms when your blood sugar is falling too low. Warning signs are listed later in this leaflet. You must think carefully about when to have your meals, how often to exercise and how much to do. You must also keep a close watch on your blood sugar levels by testing your blood glucose often.</li><li>A few people who have had hypoglycaemia after switching from animal insulin to human insulin have reported that the early warning symptoms were less obvious or different. If you often have hypoglycaemia or have difficulty recognising it, please discuss this with your doctor.</li><li>If you answer YES to any of the following questions, tell your doctor, pharmacist or diabetes nurse</li></ul><p style="text-indent:50px">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have you recently become ill?</p><p style="text-indent:50px">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do you have trouble with your kidneys or liver?</p><p style="text-indent:50px">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are you exercising more than usual?</p><ul><li>The amount of insulin you need may also change if you drink alcohol.</li><li>You should also tell your doctor, pharmacist or diabetes nurse if you are planning to go abroad. The time difference between countries may mean that you have to have your injections and meals at different times from when you are at home.</li><li>Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with pioglitazone and insulin experienced the development of heart failure. Inform your doctor as soon as possible, if you experience signs of heart failure such as unusual shortness of breath or rapid increase in weight or localised swelling (oedema).</li><li>Perform continuous rotation of the injection site to reduce the risk of developing lipodystrophy and cutaneous amyloidosis. There is a potential risk of delayed insulin absorption and worsened glycemic control following insulin injections at sites with these reactions. A sudden change in the injection site to an unaffected area has been reported to result in hypoglycemia. Blood glucose monitoring is recommended after the change in the injection site, and dose adjustment of antidiabetic medications may be considered.</li></ul><p><strong>Skin changes at the injection site</strong></p><p>The injection site should be rotated to prevent skin changes such as lumps under the skin. The insulin may not work very well if you inject into a lumpy area (See How to use Humalog). Contact your doctor if you are currently injecting into a lumpy area before you start injecting a different area. Your doctor may tell you to check your blood sugar more closely, and to adjust your insulin or your other antidiabetic medications dose.</p><p><strong>Other medicines and Humalog</strong></p><p>Your insulin needs may change if you are taking</p><ul><li>the contraceptive pill,</li><li>steroids,</li><li>thyroid hormone replacement therapy,</li><li>oral hypoglycaemics,</li><li>acetyl salicylic acid,</li><li>sulpha antibiotics,</li><li>octreotide,</li><li>&ldquo;beta<sub>2</sub> stimulants&rdquo; (for example ritodrine, salbutamol or terbutaline),</li><li>beta-blockers, or</li><li>some antidepressants (monoamine oxidase inhibitors or selective serotonin reuptake inhibitors),</li><li>danazol,</li><li>some angiotensin converting enzyme (ACE) inhibitors (for example captopril, enalapril), and</li><li>angiotensin II receptor blockers.</li></ul><p>Please tell your doctor, if you are taking or have recently taken any other medicines, including medicines obtained without a prescription (see section &ldquo;Warnings and precautions&rdquo;).</p><p><strong>Pregnancy and breast-feeding</strong></p><p>Are you pregnant or thinking about becoming pregnant, or are you breast-feeding? The amount of insulin you need usually falls during the first three months of pregnancy and increases for the remaining six months. If you are breast-feeding, you may need to alter your insulin intake or diet.</p><p>Ask your doctor for advice.</p><p><strong>&nbsp;Driving and using machines</strong></p><p>Your ability to concentrate and react may be reduced if you have hypoglycaemia. Please keep this possible problem in mind in all situations where you might put yourself and others at risk (e.g. driving a car or operating machinery). You should contact your doctor about the advisability of driving if you have:</p><ul><li>frequent episodes of hypoglycaemia</li><li>reduced or absent warning signs of hypoglycaemia</li></ul><p><strong>Humalog contains sodium</strong></p><p>This medicine contains less than 1&nbsp;mmol sodium (23&nbsp;mg) per dose, that is to say essentially &lsquo;sodium-free&rsquo;.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use Humalog exactly as your doctor has told you. You should check with your doctor if you are not sure.</p><p><strong>Dose</strong></p><ul><li>You should normally inject Humalog within 15 minutes of a meal. If you need to, you can inject soon after a meal. But your doctor will have told you exactly how much to use, when to use it, and how often. These instructions are only for you. Follow them exactly and visit your diabetes clinic regularly.</li><li>If you change the type of insulin you use (for example from a human or animal insulin to a Humalog product), you may have to take more or less than before. This might just be for the first injection or it may be a gradual change over several weeks or months.</li><li>Inject Humalog under the skin. You should only inject it into a muscle if your doctor has told you to.</li></ul><p><strong>Preparing Humalog</strong></p><ul><li>Humalog is already dissolved in water, so you do not need to mix it. But you must use it <strong>only </strong>if it looks like water. It must be clear, have no colour and no solid pieces in it. Check each time you inject yourself.</li></ul><p><strong>Injecting Humalog</strong></p><ul><li>First wash your hands.</li><li>Before you make an injection, clean your skin as you have been instructed. Clean the rubber stopper on the vial, but do not remove the stopper.</li><li>Use a clean, sterile syringe and needle to pierce the rubber stopper and draw in the amount of Humalog you want. Your doctor or clinic will tell you how to do this. <strong>Do not share your needles and syringes.</strong></li><li>Inject under the skin, as you were taught. Do not inject directly into a vein. After your injection, leave the needle in the skin for five seconds to make sure you have taken the whole dose. Do not rub the area you have just injected. Make sure you inject at least half an inch (1&nbsp;cm) from the last injection and that you &lsquo;rotate&rsquo; the places you inject, as you have been taught in order to reduce the risk of lipodystrophy and cutaneous amyloidosis. It doesn&rsquo;t matter which injection site you use, either upper arm, thigh, buttock or abdomen, your Humalog injection will still work quicker than soluble human insulin.</li><li>Your doctor will tell you if you have to mix Humalog with one of the human insulins. For example if you do need to inject a mixture, draw the Humalog into the syringe before the long acting insulin. Inject the liquid as soon as you have mixed it. Do the same thing every time. You should not normally mix Humalog with one of the mixtures of human insulins. You should never mix Humalog with insulins produced by other manufacturers or animal insulins.</li><li>You must not administer Humalog by the intravenous route. Inject Humalog as your physician or nurse has taught you. Only your physician can administer Humalog by the intravenous route. He will only do this under special circumstances such as surgery or if you are ill and your glucose levels are too high.</li></ul><p><strong>Using Humalog in an infusion pump</strong></p><ul><li>Only certain CE-marked insulin infusion pumps may be used to infuse insulin lispro. Before infusing insulin lispro, the manufacturers instructions should be studied to ascertain the suitability or otherwise for the particular pump. Read and follow the instructions in the product literature supplied with the infusion pump.</li><li>Be sure to use the correct reservoir and catheter for your pump.</li><li><u>Changing of the infusion set (tubing and needle) must be done according to the instructions in the product information supplied with the infusion set.</u></li><li>In the event of a hypoglycaemic episode, the infusion should be stopped until the episode is resolved. If repeated or severe low blood glucose levels occur, notify your doctor or clinic and consider the need to reduce or stop your insulin infusion.</li><li>A pump malfunction or obstruction of the infusion set can result in a rapid rise in glucose levels. If an interruption to insulin flow is suspected, follow the instructions in the product literature and if appropriate, notify your doctor or clinic.</li><li>When used with an insulin infusion pump, Humalog should not be mixed with any other insulin.</li></ul><p><strong>If you use more Humalog than you should</strong></p><p>If you use more Humalog than you need or are unsure how much you have injected, a low blood sugar may occur.&nbsp; Check your blood sugar.</p><p>If your blood sugar is low <strong>(mild hypoglycaemia)</strong>, eat glucose tablets, sugar or drink a sugary drink. Then eat fruit, biscuits, or a sandwich, as your doctor has advised you and have some rest. This will often get you over mild hypoglycaemia or a minor insulin overdose. If you get worse and your breathing is shallow and your skin gets pale, tell your doctor at once. A glucagon injection can treat quite severe hypoglycaemia. Eat glucose or sugar after the glucagon injection. If you do not respond to glucagon, you will have to go to hospital. Ask your doctor to tell you about glucagon.</p><p><strong>If you forget to use Humalog</strong></p><p>If you take less Humalog than you need or are unsure how much you have injected, a high blood sugar may occur.&nbsp; Check your blood sugar.</p><p>If hypoglycaemia (low blood sugar) or hyperglycaemia (high blood sugar) is not treated they can be very serious and cause headaches, nausea, vomiting, dehydration, unconsciousness, coma or even death (see A and B in section 4 &ldquo;Possible Side Effects&rdquo;).</p><p><strong>Three simple steps </strong>to avoid hypoglycaemia or hyperglycaemia are:</p><ul><li>Always keep spare syringes and a spare vial of Humalog.</li><li>Always carry something to show you are diabetic.</li><li>Always carry sugar with you.</li></ul><p><strong>If you stop using Humalog.</strong></p><p>If you take less Humalog than you need, a high blood sugar may occur. Do not change your insulin unless your doctor tells you to.</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Humalog can cause side effects, although not everybody gets them.</p><p><em>&nbsp;</em>Systemic allergy is rare (greater than or equal to&nbsp;1/10,000 to &lt;1/1,000). The symptoms are as follows:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash over the whole body&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood pressure dropping</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty in breathing&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart beating fast</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; wheezing&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sweating.</p><p>If you think you are having this sort of insulin allergy with Humalog, tell your doctor at once.</p><p>Local allergy is common (greater than or equal to 1/100 to &lt;1/10).&nbsp; Some people get redness, swelling or itching around the area of the insulin injection. This usually clears up in anything from a few days to a few weeks. If this happens to you, tell your doctor.</p><p>Lipodystrophy is uncommon (greater than or equal to 1/1,000 to &lt;1/100). If you inject insulin too often at the same place, the fatty tissue may either shrink (lipoatrophy) or thicken (lipohypertrophy). Lumps under the skin may also be caused by build-up of a protein called amyloid (cutaneous amyloidosis). The insulin may not work very well if you inject into a lumpy area. Change the injection site with each injection to help prevent these skin changes.</p><p>Lipodystrophy and cutaneous amyloidosis may occur at the injection site and delay local insulin absorption. Continuous rotation of the injection site within the given injection area may help to reduce or prevent these reactions</p><p>Oedema (e.g. swelling in arms, ankles; fluid retention) has been reported, particularly at the start of insulin therapy or during a change in therapy to improve control of your blood glucose.</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in section 6. By reporting side effects you can help provide more information on the safety of this medicine.</p><p><strong>Common problems of diabetes</strong></p><p><strong>A. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypoglycaemia</strong></p><p>Hypoglycaemia (low blood sugar) means there is not enough sugar in the blood. This can be caused if:</p><ul><li>you take too much Humalog or other insulin;</li><li>you miss or delay meals or change your diet;</li><li>you exercise or work too hard just before or after a meal;</li><li>you have an infection or illness (especially diarrhoea or vomiting);</li><li>there is a change in your need for insulin; or</li><li>you have trouble with your kidneys or liver which gets worse.</li></ul><p>Alcohol and some medicines can affect your blood sugar levels.</p><p>The first symptoms of low blood sugar usually come on quickly and include the following:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tiredness&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&bull;&nbsp;&nbsp; rapid heartbeat</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervousness or shakiness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sick</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&bull;&nbsp; cold sweat.</p><p>While you are not confident about recognising your warning symptoms, avoid situations, e.g. driving a car, in which you or others would be put at risk by hypoglycaemia.</p><p><strong>B. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hyperglycaemia and diabetic ketoacidosis</strong></p><p>Hyperglycaemia (too much sugar in the blood) means that your body does not have enough insulin. Hyperglycaemia can be brought about by:</p><ul><li>not taking your Humalog or other insulin;</li><li>taking less insulin than your doctor tells you to;</li><li>eating a lot more than your diet allows; or</li><li>fever, infection or emotional stress.</li></ul><p>Hyperglycaemia can lead to diabetic ketoacidosis. The first symptoms come on slowly over many hours or days. The symptoms include the following:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sleepy&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; no appetite</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flushed face&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fruity smell on the breath</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thirst&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling or being sick</p><p>Severe symptoms are heavy breathing and a rapid pulse.&nbsp; <strong>Get medical help immediately.</strong></p><p><strong>C. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Illness</strong></p><p>If you are ill, especially if you feel sick or are sick, the amount of insulin you need may change. <strong>Even when you are not eating normally, you still need insulin.</strong> Test your urine or blood, follow your &lsquo;sick rules&rsquo;, and tell your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Before the first use store your Humalog in a refrigerator (2&deg;C &ndash; 8&deg;C). Do not freeze. Keep your vial in use in a refrigerator (2&deg;C &ndash; 8&deg;C) or at room temperature below 30&deg;C and discard after 28 days. Do not put it near heat or in the sun.</p><p>Keep out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the label and the carton. The expiry date refers to the last day of that month.</p><p>Do not use this medicine, if you notice it is coloured or it has solid pieces in it. You must use it <strong>only</strong> if it looks like water. Check this each time you inject yourself.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Humalog 100&nbsp;units/ml solution for injection in vial contains</strong></p><ul><li>The active substance is insulin lispro. Insulin lispro is made in the laboratory by a &lsquo;recombinant DNA technology&rsquo; process. It is a changed form of human insulin and so is different from other human and animal insulins. Insulin lispro is closely related to human insulin which is a natural hormone made by the pancreas.</li><li>The other ingredients are m-cresol, glycerol, dibasic sodium phosphate 7 H<sub>2</sub>O, zinc oxide and water for injection. Sodium hydroxide or hydrochloric acid may have been used to adjust the acidity.<em> </em></li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Humalog 100 units/ml, solution for injection is a sterile, clear, colourless, aqueous solution and contains 100 units of insulin lispro in each millilitre (100 units/ml) solution for injection. Each vial contains 1000 units (10 millilitres). Humalog 100 units/ml, solution for injection in vial comes in a pack of 1 vial, 2 vials or a multipack of 5 x 1 vial. Not all pack sizes may be marketed.
	

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorization Holder:</p><p>Eli Lilly and Company, Indianapolis, IN. 46285. United States.</p><p>Manufacturer, Primary and Secondary Packaging Site:</p><p>Eli Lilly and Company, Indianapolis, Indiana 46285, USA</p><p>For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:</p><p>Eli Lilly &amp; Company &ndash; Saudi Arabia</p><p>PO Box 92120</p><p>16th Floor, Building Number 3074,</p><p>Tower B, Olaya Towers</p><p>Prince Mohamed Ibn Abdulaziz Street</p><p>Olaya, Riyadh</p><p>Kingdom of Saudi Arabia</p><p>Direct Line:&nbsp; +966 11 461 7800, +966 11 4617850&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Fax: +966 11 217 9900</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                	September 2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يستخدم هيومالوج لعلاج داء السكري. ويبدأ مفعوله على نحو أسرع من الإنسولين البشري الطبيعي لأن جزيء الإنسولين خضع لتغيير بسيط.</p><p dir="RTL">تصاب بداء السكري إن لم يقم البنكرياس لديك بإنتاج الإنسولين بقدر كافٍ لضبط مستوى الجلوكوز بالدم. ويعد مستحضر هيومالوج بديلاً لك عن الإنسولين ويستخدم لضبط مستوى الجلوكوز على المدى البعيد. يبدأ هيومالوج في العمل على نحو شديد السرعة ويستمر مفعوله لفترة أقصر من الإنسولين المذاب (2 إلى 5 ساعات). ينبغي لك في العادة أن تستخدم هيومالوج خلال 15 دقيقة قبل تناول الوجبة الغذائية.</p><p dir="RTL">قد ينصحك طبيبك باستخدام هيومالوج إضافة إلى أحد مستحضرات الإنسولين طويل المفعول. ولكل نوع من الإنسولين نشرة معلومات للمريض لمنحك المعلومات المطلوبة عنه. لا تقدم على تغيير مستحضر الإنسولين الذي تستخدمه ما لم ينصحك طبيبك بذلك. كن شديد الحذر إذا أقدمت على تغيير مستحضر الإنسولين الذي تستخدمه.</p><p dir="RTL">يعد هيومالوج ملائماً للاستخدام في علاج البالغين والأطفال.. &nbsp;&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">عليك الامتناع عن استخدام هيومالوج في الحالات التالية:</p><ul dir="rtl"><li>إذا ساورك شك بأن <strong>مستوى الجلوكوز بالدم لديك قد بد</strong> <strong>أ</strong><strong> بالانخفاض</strong> <strong>(انخفاض مستوى السكّر في الدّم</strong><strong>)</strong>. ترشدك هذه النشرة في فقرات لاحقة عن كيفية التعامل مع الانخفاض البسيط بمستوى جلوكوز الدم (انظر القسم :3 إذا استخدمت جرعة زائدة من هيومالوج أكثر مما يجب).</li><li>إذا كنت مصاباً بحساسية لإنسولين ليسبرو أو غيره من مكونات الدواء (مفصلة في القسم 6).</li></ul><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><ul dir="rtl"><li>احرص دائماً على التحقق من العبوة وملصقة القلم المعبأ للتأكد من اسم ونوع الإنسولين حال شرائه من الصيدلية. تأكد من حصولك على هيومالوج الذي نصحك طبيبك باستخدامه.</li><li>إذا كانت مستويات سكر الدم لديك منضبطة، بدرجة جيدة، مع استخدام علاج الإنسولين الذي تعتمد عليه حالياً، فقد لا تشعر بالأعراض التحذيرية إذا انخفض سكر الدم لديك انخفاضاً شديداً. وسيتم سرد العلامات التحذيرية لاحقاً في هذه النشرة. ولابد أن تفكر باهتمام في مواعيد تناول وجباتك الغذائية، وعدد مرات ممارسة التمرينات البدنية والقدر المسموح به منها. ولابد لك أيضاً من المداومة على مراقبة مستويات سكر الدم لديك من خلال قياس مستوى جلوكوز الدم لديك بصفة متكررة.</li><li>بعض الناس ممن أصيبوا بانخفاض مستوى جلوكوز الدم عقب التحول من استخدام إنسولين حيواني إلى استخدام إنسولين بشري، أفادوا بأن الأعراض التحذيرية المبكرة كانت أقل وضوحاً أو مختلفة. إذا كنت تصاب بانخفاض مستوى جلوكوز الدم على نحو متكرر أو تجد صعوبة في تمييزه، ناقش هذا الأمر مع طبيبك.</li><li>إذا كانت إجابتك عن أي من الأسئلة التالية هي <strong>نعم</strong>، فبادر بإبلاغ طبيبك أو الصيدلي أو الممرضة المعنية بداء السكري</li></ul><p dir="RTL" style="text-indent:50px">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هل أصبت مؤخراً بوعكة صحية؟</p><p dir="RTL" style="text-indent:50px">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هل تعاني من متاعب بالكلى أو الكبد؟</p><p dir="RTL" style="text-indent:50px">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هل تمارس تشاطاً بدنياً فوق المعتاد؟&nbsp;&nbsp; &nbsp;</p><ul dir="rtl"><li>قد تتغير جرعة الإنسولين التي تحتاجها أيضاً إذا كنت تتناول الكحول.</li><li>ينبغي أيضاً أن تبلغ طبيبك أو الصيدلي أو الممرضة المعنية بداء السكري، إذا كنت تنوي السفر للخارج. فإن فوارق التوقيت بين البلدان قد تجعلك بحاجة إلى تناول الحقن والوجبات الغذائية في مواعيد مختلفة عما اعتدته في بلدك.</li><li>بعض المرضى من المصابين بالنوع الثاني من داء السكري لفترة طويلة مع إصابتهم بمرض قلبي أو سكتة دماغية سابقة، والذين جرى علاجهم بكل من عقار بيوجليتازون والإنسولين، قد أصيبوا بالفشل القلبي. فبادر بإبلاغ طبيبك المعالج وبأسرع ما يمكن، إذا ظهرت عليك علامات الفشل القلبي، ومنها الشعور بضيق غير معتاد بالتنفس أو زيادة وزن الجسم بمعدل سريع أو تورم بموضع معين من الجسم (وذمة).</li><li>يجب مناوبة مواقع الحقن باستمرار للحد من خطر الإصابة بالحثل الشحمي والداء النشواني الجلدي. هناك خطر محتمل لتأخير امتصاص الأنسولين وتفاقم السيطرة على نسبة السكر في الدم بعد حقن الأنسولين في المواقع التي تعاني من هذه التفاعلات. لقد الإبلاغ عن حدوث تغير مفاجئ في موقع الحقن في منطقة غير متأثرة مما أدى إلى نقص السكر في الدم. يوصى بمراقبة الجلوكوز في الدم بعد تغيير موقع الحقن، ويمكن النظر في تعديل جرعة الأدوية المضادة لمرض السكري.&nbsp; &nbsp;</li></ul><p dir="RTL"><strong>تغيرات الجلد في موقع الحقن</strong></p><p dir="RTL">يجب تدوير موقع الحقن لمنع تغيرات الجلد مثل الكتل تحت الجلد. قد لا يعمل الإنسولين جيدًا إذا قمت بالحقن في منطقة متكتلة (انظر كيفية استخدام هيومالوج كويك بن). اتصل بطبيبك إذا كنت تحقن حاليًا في منطقة متكتلة قبل البدء في حقن منطقة مختلفة. قد يخبرك طبيبك بفحص نسبة السكر في الدم عن كثب، وتعديل جرعة الإنسولين أو الأدوية الأخرى المضادة لمرض السكر.</p><p dir="RTL"><strong>استخدام أدوية أخرى مع هيومالوج</strong></p><p dir="RTL">قد تتغير احتياجاتك من الإنسولين إذا كنت تتناولين</p><ul dir="rtl"><li>أقراص منع الحمل،</li><li>الستيرويدات،</li><li>العلاج التعويضي لهرمون الغدة الدرقية،</li><li>أدوية فموية مخفضة لمستوى جلوكوز الدم،</li><li>حمض أسيتيل ساليسيليك،</li><li>المضادات الحيوية المحتوية على سلفا،</li><li>عقار أوكتيرويد،</li><li>منبهات مستقبلات بيتا 2 (مثل ريتودرين أو سالبيوتامول أو تيربيوتالين)،</li><li>حاصرات بيتا، أو</li><li>بعض مضادات الاكتئاب (مثبطات الإنزيم المؤكسد أحادي الأمين أو مثبطات إعادة امتصاص سيروتونين الاختيارية)،</li><li>عقار دانازول،</li><li>بعض مثبطات الإنزيم المحول للأنجيوتنسين (مثل كابتوبريل و إنالابريل)،</li><li>حاصرات مستقبلات أنجيوتنسين 2.</li></ul><p dir="RTL">فضلاً، أبلغ طبيبك المعالج بأية أدوية أخرى تتناولها حالياً أو تناولتها مؤخراً، بما في ذلك الأدوية التي يتم صرفها دون وصفة طبية (انظر القسم &quot;تحذيرات واحتياطات&quot;).</p><p dir="RTL"><strong>الحمل والإرضاع</strong></p><p dir="RTL">هل أنت حامل أو تفكرين في الحمل أو ترضعين؟ إن القدر الذي تحتاجينه من الإنسولين عادة ما ينخفض خلال الثلاثة أشهر الأولى من فترة الحمل ويرتفع خلال الستة أشهر الباقية. وإذا كنت ترضعين، فقد تحتاجين لتعديل جرعة الإنسولين التي تتناولينها أو تغيير نظامك الغذائي.</p><p dir="RTL">بادري باستشارة طبيبك المعالج.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">قد تنخفض قدرتك على التركيز ورد الفعل إذا انخفض مستوى جلوكوز الدم لديك. يرجى أن تضع في اعتبارك هذه المشكلة المحتملة في كل موقف قد تعرض فيه نفسك أو غيرك للخطر (مثل قيادة السيارة أو تشغيل آلة). وينبغي لك أن تتواصل مع طبيبك المعالج طلباً لمشورته فيما يتعلق بأمر القيادة إذا كنت تعاني من:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات متكررة من انخفاض مستوى جلوكوز الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف أو عدم ظهور العلامات التحذيرية الخاصة بانخفاض مستوى جلوكوز الدم.</p><p dir="RTL"><strong>يحتوي هيومالوج&nbsp;على الصوديوم</strong></p><p dir="RTL">تحتوي كلّ جرعة من هذا الدواء على أقلّ من 1 ملّيمول&rlm; (23 مغ) من الصوديوم، أي أنّه يعتبر &quot;خالٍ عمليًا من الصوديوم&quot;.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احرص دائماً على استخدام هيومالوج كيفما أخبرك طبيبك بالضبط. ينبغي أن تراجع الأمر مع طبيبك المعالج إن لم تكن واثقاً من كيفية استخدامه.</p><p dir="RTL"><strong>الجرعة</strong></p><ul dir="rtl"><li>ينبغي، في الظروف العادية، أن تقوم بحقن هيومالوج خلال 15 دقيقة قبل تناول الوجبة الغذائية. ويمكنك حقن الجرعة بعد الوجبة مباشرة إن كنت بحاجة لذلك. إلا أن طبيبك المعالج سوف يخبرك، على وجه الدقة، بالجرعة التي ينبغي لك حقنها وكذلك مواعيد وعدد مرات الحقن. وستكون هذه التعليمات خاصة بك وحدك. وعليك اتباعها بدقة والالتزام بزيارة عيادة السكري التي تتردد عليها بانتظام.</li><li>إذا أقدمت على تغيير نوع الإنسولين الذي تستخدمه (مثل التحول من استخدام إنسولين بشري أو حيواني إلى استخدام أحد منتجات هيومالوج)، فقد يتوجب عليك أن تتناول جرعة أكبر أو أقل من ذي قبل. وقد يقتصر ذلك على الحقن الأول فقط أو يكون تغييراً تدريجياً يستغرق عدة أسابيع أو شهور.</li><li>قم بحقن هيومالوج تحت الجلد. ولا تقدم على حقنه في العضل ما لم ينصحك طبيبك المعالج بذلك.</li></ul><p dir="RTL"><strong>إعداد هيومالوج</strong></p><ul dir="rtl"><li>إن هيومالوج مذاب بالفعل في الماء، لذلك فلست بحاجة إلى مزجه. ولكن لابد لك أن لا تقدم على استخدامه ما لم يبدُ كالماء. فلابد أن يكون رائقاً، عديم اللون، خالياً من أية كتل جامدة. تحقق من ذلك في كل مرة تقوم فيها بحقن نفسك.</li></ul><p dir="RTL"><strong>حقن هيومالوج</strong></p><ul dir="rtl"><li>اغسل يديك أولاً.</li><li>نظف جلدك بحسب التعليمات قبل قيامك بالحقن. نظف السدادة المطاطية للقارورة، ولكن لا تقم بإزالتها.</li><li>عليك استخدام إبر نظيفة ومعقمة لاختراق السدادة المطاطية وسحب الكمية التي تريدها من هيومالوج. سيخبرك طبيبك أو العيادة بطريقة القيام بذلك. <strong>لا تتشارك الإبر والمحاقن مع آخرين.</strong></li><li>قم بالحقن تحت الجلد كما تعلمت. تجنب الحقن مباشرة داخل أحد الأوردة. بعد الحقن، اترك الإبرة داخل الجلد لخمس ثوان لتتأكد من تناولك للجرعة كاملة. تجنب حك موضع الحقن. تأكد من وجود مسافة لا تقل نصف بوصة (1 سم) بين موضع الحقن وموضع الحقن السابق واحرص على تغيير مواضع الحقن، كما تعلمت للتقليل من خطر الإصابة بالحثل الشحمي والداء النشواني الجلدي. واختيار موضع الحقن لا يصنع فارقاً، سواء كان في أعلى الذراع أو الفخذ أو الردف أو البطن، إذ أن تأثير جرعة هيومالوج سوف يبدأ في كل الأحوال على نحو أسرع من الإنسولين البشري المذاب.</li><li>سيخبرك طبيبك لو كان مسموحاً لك خلط هيومالوج مع أحد مستحضرات الإنسولين البشري الأخرى. على سبيل المثال: إذا كنت في حاجة لحقن خليط، اسحب هيومالوج إلى المحقن قبل الإنسولين طويل المفعول. احقن السائل فور خلطه. قم بذلك بنفس الطريقة في كل مرة. لا يجب أن تقوم في المعتاد بخلط هيومالوج مع أحد خلطات الإنسولين البشري الأخرى. لا يجب أبداً أن تخلط هيومالج مع مستحضرات الإنسولين التي أنتجها مُصنّعين آخرين أو مع مستحضرات الإنسولين الحيوانية.</li><li>يحظر أن تقوم بحقن هيومالوج في الوريد. وعليك حقن هيومالوج بالكيفية التي علمك إياها طبيبك المعالج أو الممرضة. والطبيب فقط هو من يمكنه إعطاء هيومالوج عن طريق الوريد. ولن يقدم على ذلك إلا تحت ظروف معينة مثل خضوعك لتدخل جراحي أو إذا أصابتك حالة مرضية وكانت مستويات الجلوكوز لديك بالغة الارتفاع.&nbsp; &nbsp;&nbsp;</li></ul><p dir="RTL"><strong>&nbsp;استخدام هيومالوج داخل مضخة تسريب</strong><strong> </strong><strong>(مضخات الانسولين)</strong></p><ul dir="rtl"><li>يمكن استخدام مضخات تسريب إنسولين معينة مميزة بالحرفين CE<strong> </strong>ولا يستخدم غيرها لتسريب<strong> </strong>إنسولين ليسبرو. وقبل الإقدام على استخدام إنسولين ليسبرو عن طريق التسريب، ينبغي دراسة التعليمات الصادرة من الشركات المصنعة للتأكد من ملاءمة أو عدم ملاءمة مضخة معينة. وعليك قراءة واتباع الإرشادات الواردة في نشرة المنتج التي تأتيك مع مضخة التسريب.</li><li>تأكد من استخدام الخزان والقثطرة الملائمين للمضخة الخاصة بك.</li><li><u>قم بتغيير عدة التسريب (الأنابيب والإبرة) بحسب التعليمات الواردة في نشرة المنتج التي تأتيك مع عدة التسريب.</u></li><li>في حالة حدوث نوبة من انخفاض مستوى جلوكوز، يجب إيقاف التسريب لحين انتهاء هذه النوبة. فإن تكررت أو حدث انخفاض شديد بمستويات جلوكوز الدم ، فلتبلغ طبيبك المعالج أو العيادة التي تتردد عليها ولتأخذ بعين الاعتبار حاجتك إلى تقليل أو إيقاف تسريب الإنسولين.</li><li>قد يؤدي حدوث عطل بالمضخة أو انسداد بجهاز التسريب إلى حدوث ارتفاع سريع بمستويات الجلوكوز. فإذا اشتبهت بحدوث اضطراب في تيار الإنسولين، فعليك اتباع التعليمات الموجودة بنشرة المنتج، ويمكنك إبلاغ طبيبك المعالج أو العيادة إن رأيت ذلك ملائماً.</li><li>عند استخدامه من خلال مضخة تسريب إنسولين، يحظر خلط هيومالوج مع أي مستحضر آخر من مستحضرات الإنسولين.</li></ul><p dir="RTL">&nbsp;<strong>إذا استخدمت جرعة زائدة من هيومالوج&nbsp;أكثر مما يجب</strong></p><p dir="RTL">إذا استخدمت جرعة زائدة من هيومالوج أو غير متأكد من الكمية التي حقنت، فقد ينخفض مستوى السكر بالدم لديك. عليك إذاً بقياس مستوى السكر بالدم لديك. فإذا كان منخفضاً (<strong>انخفاض بسيط لمستوى الجلوكوز بالدم)</strong>، فبادر بتناول أقراص الجلوكوز أو السكر أو مشروب سكري. ثم تناول الفاكهة أو البسكويت أو ساندويتش، حسبما نصحك طبيبك وخذ قسطاً من الراحة. بهذه الطريقة، ستتمكن غالباً من تجاوز الانخفاض البسيط بمستوى جلوكوز الدم أو الزيادة البسيطة في جرعة الإنسولين. أما إذا ساءت حالتك وصار تنفسك ضحلاً وجلدك شاحباً، فعليك إبلاغ طبيبك على الفور. يمكن معالجة الانخفاض الشديد بمستوى جلوكوز الدم بحقن عقار جلوكاجون. عليك أن تأكل جلوكوز أو سكر بعد حقن عقار جلوكاجون. فإن لم تستجب لعقار جلوكاجون، فسيتوجب عليك الذهاب للمستشفى. اسأل طبيبك عن عقار جلوكاجون.</p><p dir="RTL"><strong>إذا نسيت تناول هيومالوج</strong></p><p dir="RTL">إذا أخذت قدراً أقل مما تحتاج من هيومالوج أو غير متأكد من الكمية التي حقنت، فقد يرتفع مستوى سكر الدم. وعليك قياس مستوى السكر بالدم لديك.</p><p dir="RTL">إن لم يتم علاج أي من حالتي انخفاض أو ارتفاع مستوى السكر بالدم، فقد يمثلان خطورة شديدة ويسببان الصداع أوالغثيان أو التقيؤ أوالجفاف أو فقدان الوعي أوالغيبوبة أو حتى الوفاة. (انظر الفقرتين أ و ب في القسم 4 الآثار الجانبية المحتملة).&nbsp;</p><p dir="RTL"><strong>ثلاث خطوات بسيطة </strong>لتفادي الإصابة بانخفاض أو ارتفاع السكر بالدم هي:</p><ul dir="rtl"><li>احرص دائماً على الاحتفاظ بمحاقن احتياطية وقارورة احتياطية من هيومالوج.</li><li>احرص دائماً على حمل ما يفيد بأنك مصاب بمرض السكري.</li><li>احرص دائماً على حمل قدر من السكر معك.</li></ul><p dir="RTL"><strong>إذا توقفت عن تناول هيومالوج</strong></p><p dir="RTL">إذا أخذت قدراً أقل مما تحتاج من هيومالوج، فقد يرتفع مستوى سكر الدم. لا تقدم على تغيير مستحضر الإنسولين الذي تستخدمه ما لم ينصحك طبيبك المعالج بذلك.</p><p dir="RTL">إذا كانت لديك أية استفسارات أخرى بخصوص استخدام هذا المنتج، فاسأل طبيبك أو الصيدلي. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو شأن كافة الأدوية، فقد يتسبب هذا الدواء في حدوث آثار جانبية، إلا أنها لا تصيب كل من يستخدمه.</p><p dir="RTL">أما الحساسية الجهازية فنادرة (&ge; 10000/1 إلى &lt; 1000/1). وتكون أعراضها كالتالي:</p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي على عامة الجسم&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في التنفس&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أزيز بالصدر&nbsp;&nbsp;</p></td><td style="vertical-align:top"><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض ضغط الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سرعة نبضات القلب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التعرق</p></td></tr></tbody></table><p dir="RTL">إذا ساورك شك بأنك أصبت بهذا النوع من الحساسية للإنسولين أثناء استخدامك &nbsp;هيومالوج، فبادر بإبلاغ طبيبك فوراً.</p><p dir="RTL">الحساسية الموضعية شائعة (&ge;&nbsp;1/100 إلى &lt;1/10). يعاني بعض الأشخاص من احمرار أو تورّم أو حكّة حول موضع تلقّي حقنة الإنسولين. عادة ما تزول هذه العلامات في غضون بضعة أيام إلى بضعة أسابيع. إذا عانيت من أيّ منها، عليك إبلاغ طبيبك.&nbsp;&nbsp;&nbsp; &nbsp;</p><p dir="RTL">حدوث تغيرات شحمية بالجلد هو أثر غير شائع (&ge; 1000/1 إلى &lt; 100/1). إذا كنت تحقن الإنسولين في نفس المكان غالبا، فقد يتقلص النسيج الدهني (ضمور شحمي) أو يتسمك (تضخم شحمي). قد تتكون الكتل الموجودة تحت الجلد أيضًا بسبب تراكم بروتين يسمى النشواني (الداء النشواني الجلدي). قد لا يعمل الإنسولين جيدًا إذا قمت بالحقن في منطقة متكتلة. قم بتغيير موقع الحقن مع كل حقنة للمساعدة في تجنّب هذه التغييرات الجلدية.</p><p dir="RTL">قد يحدث الحثل الشحمي والداء النشواني الجلدي في موقع الحقن ويؤخر امتصاص الأنسولين المحلي. يمكن أن تساعد مناوبة مواقع الحقن باستمرار داخل منطقة الحقن المعينة على تقليل أو منع هذه التفاعلات.</p><p dir="RTL">وردت تقارير بخصوص حدوث وذمة (مثل تورم بالذراعين والكاحلين؛ احتباس السوائل)، وبخاصة عند بدء العلاج بالإنسولين أو أثناء تغيير العلاج لتحسين التحكم في مستوى جلوكوز الدم لديك.</p><p dir="RTL"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL">في حالة إصابتك بأية آثار جانبية، فأبلغ طبيبك أو الممرضة. يتضمن ذلك أية آثار جانبية محتملة وغير مفصلة في هذه النشرة. يمكنك أيضًا الإبلاغ عن أية آثار جانبية بشكل مباشر عن طريق النظام الوطني للإبلاغ عن الآثار الجانبية المذكور في المقطع 6. إن إبلاغك عن الآثار الجانبية يساعد في توفير معلومات إضافية عن سلامة استخدام هذا العقار.</p><p dir="RTL"><strong>المشكلات الشائعة المتعلقة بمرض السكري</strong></p><p dir="RTL"><strong>&nbsp;(أ) انخفاض مستوى الجلوكوز بالدم &nbsp;&nbsp;&nbsp;</strong></p><p dir="RTL">إن انخفاض مستوى الجلوكوز بالدم إنما يعني عدم وجود قدر كاف من السكر بالدم. وقد يحدث في الحالات التالية:</p><ul dir="rtl"><li>إذا تناولت قدراً زائداً من هيومالوج &nbsp;أو غيره من مستحضرات الإنسولين؛</li><li>إذا نسيت أو تأخرت في تناول الوجبات الغذائية أو غيرت النظام الغذائي الخاص بك؛</li><li>إذا مارست تمرينات بدنية شاقة أو قمت بعمل شاق قبل أو بعد الوجبة مباشرة؛</li><li>إذا كنت مصاباً بعدوى أو حالة مرضية (خاصة الإسهال أو التقيؤ)؛</li><li>إذا حدث تغير في مدى احتياجك للإنسولين؛ أو</li><li>إذا كنت تعاني من متاعب بالكلى أو الكبد ثم ساءت حالتك.</li></ul><p dir="RTL">قد يؤثر الكحول وبعض الأدوية على مستويات السكر بالدم لديك.</p><p dir="RTL">عادة ما تظهر الأعراض الأولى لانخفاض مستوى جلوكوز الدم على نحو سريع وتشمل ما يلي:</p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالإرهاق</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العصبية أو الرعشة&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصداع&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td style="vertical-align:top"><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تسارع ضربات القلب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالإعياء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العرق البارد</p></td></tr></tbody></table><p dir="RTL">إن لم تكن واثقاً بقدرتك على تمييز الأعراض التحذيرية التي تطرأ عليك، فعليك تجنب المواقف التي قد تعرضك أو تعرض الآخرين للخطر حال حدوث انخفاض مستوى جلوكوز الدم (مثل قيادة السيارة).</p><p dir="RTL"><strong>(ب) ارتفاع مستوى جلوكوز الدم والحماض الكيتوني السكري &nbsp;</strong></p><p dir="RTL">إن ارتفاع مستوى الجلوكوز بالدم إنما يعني أن جسمك ليس لديه قدر كاف من الإنسولين. وقد ينشأ عن:</p><ul dir="rtl"><li>عدم تناول جرعتك من هيومالوج أو غيره من مستحضرات الإنسولين؛</li><li>أخذ جرعة أقل من تلك التي وصفها لك طبيبك المعالج؛</li><li>تناول قدر من الطعام يفوق ما يسمح به نظامك الغذائي؛ أو</li><li>الإصابة بالحمى أو العدوى أو التوتر العاطفي.</li></ul><p dir="RTL">قد يؤدي ارتفاع مستوى جلوكوز الدم &nbsp;)ارتفاع مستوى السكّر في الدّم (إلى حدوث حالة الحماض الكيتوني السكري. وعادة ما تظهر الأعراض الأولى ببطء حيث تستغرق ساعات أو أيام طوال. وتتضمن الأعراض ما يلي:</p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالنعاس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورد الوجه&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العطش&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">&nbsp;</p></td><td style="vertical-align:top"><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقد الشهية للطعام</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رائحة فاكهية تصدر عند التنفس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالإعياء أو حدوث الإعياء</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table><p dir="RTL">وتتمثل الأعراض الشديدة في عمق التنفس وتسارع النبض. <strong>ينبغي أن تحصل على مساعدة طبية فوراً. </strong></p><p dir="RTL"><strong>&nbsp;(ت) المرض</strong></p><p dir="RTL">إذا كنت مريضاً، خاصة إذا شعرت بالإعياء أو أصبت فعلاً بالإعياء، فقد تتغير جرعة الإنسولين التي تحتاجها.<strong> حتى وإن لم تأكل على النحو العادي، فما تزال بحاجة إلى الإنسولين.</strong> قم بإجراء اختبار لكل من البول والدم واتبع القواعد المتعلقة بالحالات المرضية وأبلغ طبيبك بالأمر.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ هيومالوج في الثلاجة (ما بين 2 و 8 درجات مئويّة) قبل الاستعمال الأول. ولا يجمد. احتفظ بقارورتك التي هي قيد الاستخدام في الثلاجة (2 - 8 درجات مئويّة) أو تحت درجة حرارة الغرفة أقل من 30 درجة مئويّة وتخلص منها بعد 28 يوماً. لا تضعها بالقرب من الحرارة أو تعرضها للشمس.</p><p dir="RTL">يحفظ بعيداً عن نظر ومتناول الأطفال.</p><p dir="RTL">يحظر استخدام هذا الدواء بعد تاريخ انتهاء الصلاحية المدون على الملصقة والعلبة. يشير تاريخ انتهاء الصلاحية إلى آخر يوم من الشهر المذكور.</p><p dir="RTL">لا تستخدم هذا الدواء إذا رأيته ملوناً أو به كتل صلبة. ويحظر قطعياً أن تقدم على استخدامه <strong>ما لم يبدُ</strong> كالماء. تحقق من ذلك في كل مرة تقوم بحقن نفسك.</p><p dir="RTL">ينبغي أن لا يتم التخلص من الأدوية عن طريق ماء الصرف الصحّي أو مع النفايات المنزليّة. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. فإن تلك الإجراءات سوف تساعد على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul dir="rtl"><li>المادة الفعالة هي إنسولين ليسبرو. ويتم تصنيع إنسولين ليسبرو معملياً باستخدام تقنية تخليق الحمض النووي. وهو صورة مُعدّلة من الإنسولين البشري، لذلك فهو يختلف عن غيره من أنواع الإنسولين البشري والحيواني. ويعد إنسولين ليسبرو قريباً جداً من الإنسولين البشري الذي هو هرمون طبيعي يقوم البنكرياس بتصنيعه.</li><li>وتشتمل المكونات الأخرى على إم-كريسول و جليسرول و صوديوم فوسفات ثنائي القاعدة مع 7 جزيئات من الماء و أكسيد الزنك و ماء للحقن. قد يتم استخدام هيدروكسيد الصوديوم أو حمض هيدروكلوريك لمعادلة الحمضية.</li></ul><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>إن هيومالوج 100وحدة/ مل المعد للحقن هو عبارة عن محلول مائي معقم رائق عديم اللون يحتوي على 100 وحدة من إنسولين ليسبرو في كل ملليلتر من المحلول المعد للحقن (100 وحدة/ مل). تحتوي كل قارورة على 1000 وحدة (10 مل). يتوفر محلول هيومالوج 100وحدة/ مل المعد للحقن في عبوة من قارورة واحدة أو عبوة تحتوي على قارورتين أو 5 قارورات، وليست جميع احجام العبوات مطروحة للتسويق.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">حامل رخصة التسويق:</p><p dir="RTL">شركة ايلاي ليلي أند كامباني، انديانابوليس،IN ،46285 ، الولايات المتحدة الأمركية.</p><p dir="RTL">المصنّع و موقع التصنيع الأوّلي و الثانوي:</p><p dir="RTL">شركة ايلاي ليلي أند كامباني، انديانابوليس،IN ،46285 ، الولايات المتحدة الأمركية.</p><p dir="RTL">للحصول على أية معلومات تتعلق بهذا الدواء، يرجى الاتصال بالمندوب المحلي للشركة حاملة حقوق التسويق:</p><p dir="RTL">شركة إيلاي &nbsp;ليلي آند كومباني &ndash; المملكة العربية السعودية</p><p dir="RTL">ص.ب: 92120</p><p dir="RTL">الطابق 16، مبنى رقم 3074،</p><p dir="RTL">برج ب، أبراج العُليَّا</p><p dir="RTL">شارع الأمير محمد بن عبد العزيز</p><p dir="RTL">العُليَّا، الرياض</p><p dir="RTL">المملكة العربية السعودية</p><p dir="RTL">الخط المباشر:&nbsp; 966114617800+، 966114617850+</p><p dir="RTL">الفاكس: 966112179900+&nbsp;&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            سبتمبر 2020
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Humalog 100 units/ml, solution for injection in vial
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each ml contains 100 units of insulin lispro* (equivalent to 3.5mg). 
Vial
Each vial contains 1000 units insulin lispro in 10 ml solution.
*produced in E.coli by recombinant DNA technology.

For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for injection.
Clear, colourless, aqueous solution.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Humalog is also indicated for the initial stabilisation of diabetes mellitus.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology</p><p>The dose should be determined by the physician, according to the requirement of the patient.</p><p>Humalog may be given shortly before meals. When necessary Humalog can be given soon after meals.</p><p>Humalog takes effect rapidly and has a shorter duration of activity (2 to 5&nbsp;hours) given subcutaneously as compared with soluble insulin. This rapid onset of activity allows a Humalog injection (or, in the case of administration by continuous subcutaneous infusion, a Humalog bolus) to be given very close to mealtime. The time course of action of any insulin may vary considerably in different individuals or at different times in the same individual. The faster onset of action compared to soluble human insulin is maintained regardless of injection site. As with all insulin preparations, the duration of action of Humalog is dependent on dose, site of injection, blood supply, temperature, and physical activity.</p><p>Humalog can be used in conjunction with a longer-acting insulin or oral sulphonylurea agents, on the advice of a physician.</p><p><em>Special populations</em></p><p><em>&nbsp;Renal impairment</em></p><p>Insulin requirements may be reduced in the presence of renal impairment.</p><p><em>Hepatic impairment</em></p><p>Insulin requirements may be reduced in patients with hepatic impairment due to reduced capacity for gluconeogenesis and reduced insulin breakdown; however, in patients with chronic hepatic impairment, an increase in insulin resistance may lead to increased insulin requirements.</p><p><em>Paediatric population</em></p><p>Humalog can be used in adolescents and children (see section 5.1).</p><p><u>Method of administration</u></p><p><em>Subcutaneous use</em></p><p>Humalog preparations should be given by subcutaneous injection.</p><p>Subcutaneous administration should be in the upper arms, thighs, buttocks, or abdomen. Use of injection sites should be rotated so that the same site is not used more than approximately once a month in order to reduce the risk of lipodystrophy and cutaneous amyloidosis(see section 4.4 and 4.8).</p><p>When administered subcutaneously care should be taken when injecting Humalog to ensure that a blood vessel has not been entered. After injection, the site of injection should not be massaged. Patients must be educated to use the proper injection techniques.</p><p><em>Use of Humalog in an insulin infusion pump:</em></p><p>For subcutaneous injection of Humalog using a continuous infusion pump, you may fill the pump reservoir from a Humalog 100&nbsp;units/ml vial. Some pumps are compatible with cartridges that can be inserted intact into the pump.</p><p>Only certain CE-marked insulin infusion pumps may be used to infuse insulin lispro. Before infusing insulin lispro, the pump manufacturer&rsquo;s instructions should be studied to ascertain the suitability for the particular pump. Use the correct reservoir and catheter for the pump. When filling the pump reservoir avoid damaging it by using the correct needle length on the filling system. The infusion set (tubing and cannula) should be changed in accordance with the instructions in the product information supplied with the infusion set. In the event of a hypoglycaemic episode, the infusion should be stopped until the episode is resolved. If repeated or severe low blood glucose levels occur consider the need to reduce or stop an insulin infusion. A pump malfunction or obstruction of the infusion set can result in a rapid rise in glucose levels. If an interruption to insulin flow is suspected, follow the instructions in the pump product literature . When used with an insulin infusion pump, Humalog should not be mixed with any other insulin.</p><p><strong>&nbsp;</strong><em>Intravenous administration of insulin:</em></p><p>If necessary, Humalog may also be administered intravenously, for example: for the control of blood glucose levels during ketoacidosis, acute illnesses or during intra and post operative periods.</p><p>Humalog 100&nbsp;units /ml is available in vials if administration of intravenous injection is necessary.&nbsp;</p><p>Intravenous injection of insulin lispro should be carried out following normal clinical practise for intravenous injections, for example by an intravenous bolus or by an infusion system. Frequent monitoring of the blood glucose levels is required.</p><p>Infusion systems at concentrations from 0.1&nbsp;units/ml to 1.0&nbsp;units/ml insulin lispro in 0.9% sodium chloride or 5% dextrose are stable at room temperature for 48&nbsp;hours. It is recommended that the system is primed before starting the infusion to the patient.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Hypoglycaemia.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Traceability</u></p><p>In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.</p><p><u>Transferring a patient to another type or brand of insulin </u></p><p>Transferring a patient to another type or brand of insulin should be done under strict medical supervision. Changes in strength, brand (manufacturer), type (regular/soluble, NPH/isophane,etc.), species (animal, human, human insulin analogue), and/or method of manufacture (recombinant DNA versus animal-source insulin) may result in the need for a change in dosage. For fast-acting insulins, any patient also on basal insulin must optimise dosage of both insulins to obtain glucose control across the whole day, particularly nocturnal/fasting glucose control.</p><p><u>Vial</u></p><p>When mixing Humalog with a longer acting insulin, the shorter-acting Humalog should be drawn into the syringe first, to prevent contamination of the vial by the longer-acting insulin. Mixing of the insulins ahead of time or just before the injection should be on advice of the physician. However, a consistent routine must be followed.</p><p><strong>&nbsp;</strong><u>Hypoglycaemia and hyperglycaemia</u></p><p>Conditions which may make the early warning symptoms of hypoglycaemia different or less pronounced include long duration of diabetes, intensified insulin therapy, diabetic nerve disease or medications such as beta-blockers.</p><p>A few patients who have experienced hypoglycaemic reactions after transfer from animal-source insulin to human insulin have reported that the early warning symptoms of hypoglycaemia were less pronounced or different from those experienced with their previous insulin. Uncorrected hypoglycaemic or hyperglycaemic reactions can cause loss of consciousness, coma, or death.</p><p>The use of dosages which are inadequate or discontinuation of treatment, especially in insulin-dependent diabetics, may lead to hyperglycaemia and diabetic ketoacidosis; conditions which are potentially lethal.</p><p><u>Injection technique</u></p><p>Patients must be instructed to perform continuous rotation of the injection site to reduce the risk of developing lipodystrophy and cutaneous amyloidosis. There is a potential risk of delayed insulin absorption and worsened glycaemic control following insulin injections at sites with these reactions. A sudden change in the injection site to an unaffected area has been reported to result in hypoglycaemia. Blood glucose monitoring is recommended after the change in the injection site, and dose adjustment of antidiabetic medications may be considered.</p><p><u>Insulin requirements and dosage adjustment</u></p><p>Insulin requirements may be increased during illness or emotional disturbances.</p><p>Adjustment of dosage may also be necessary if patients undertake increased physical activity or change their usual diet. Exercise taken immediately after a meal may increase the risk of hypoglycaemia. A consequence of the pharmacodynamics of rapid-acting insulin analogues is that if hypoglycaemia occurs, it may occur earlier after an injection when compared with soluble human insulin.</p><p><u>Combination of Humalog with pioglitazone:</u></p><p>Cases of cardiac failure have been reported when pioglitazone was used in combination with insulin, especially in patients with risk factors for development of cardiac heart failure. This should be kept in mind, if treatment with the combination of pioglitazone and Humalog is considered. If the combination is used, patients should be observed for signs and symptoms of heart failure, weight gain and oedema. Pioglitazone should be discontinued, if any deterioration in cardiac symptoms occurs.</p><p><u>Avoidance of medication </u><u>errors</u></p><p>Patients must be instructed to always check the insulin label before each injection to avoid accidental mix-ups between the two different strengths of Humalog KwikPen as well as other insulin products.</p><p>Patients must visually verify the dialled units on the dose counter of the pen. Therefore, the requirement for patients to self-inject is that they can read the dose counter on the pen. Patients who are blind or have poor vision must be instructed to always get help/assistance from another person who has good vision and is trained in using the insulin device.</p><p><u>Excipients</u></p><p>This medicinal product contains less than 1&nbsp;mmol sodium (23&nbsp;mg) per dose, i.e., essentially &ldquo;sodium‑free&rdquo;.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Insulin requirements may be increased by medicinal products with hyperglycaemic activity, such as oral contraceptives, corticosteroids, or thyroid replacement therapy, danazol, beta<sub>2</sub> stimulants (such as ritodrine, salbutamol, terbutaline).</p><p>Insulin requirements may be reduced in the presence of medicinal products with hypoglycaemic activity, such as oral hypoglycaemics, salicylates (for example, acetylsalicylic acid), sulpha antibiotics, certain antidepressants (monoamine oxidase inhibitors, selective serotonin reuptake inhibitors), certain angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II receptor blockers, beta-blockers, octreotide or alcohol.</p><p>The physician should be consulted when using other medications in addition to Humalog (see section 4.4).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Data on a large number of exposed pregnancies do not indicate any adverse effect of insulin lispro on pregnancy or on the health of the foetus/newborn.&nbsp;&nbsp;</p><p>It is essential to maintain good control of the insulin-treated (insulin-dependent or gestational diabetes) patient throughout pregnancy. Insulin requirements usually fall during the first trimester and increase during the second and third trimesters. Patients with diabetes should be advised to inform their doctor if they are pregnant or are contemplating pregnancy. Careful monitoring of glucose control, as well as general health, is essential in pregnant patients with diabetes.</p><p><u>Breast-feeding</u></p><p>Patients with diabetes who are breast-feeding may require adjustments in insulin dose, diet or both.</p><p><u>Fertility</u></p><p>Insulin lispro did not induce fertility impairment in animal studies (see section 5.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The patient&rsquo;s ability to concentrate and react may be impaired as a result of hypoglycaemia. This may constitute a risk in situations where these abilities are of special importance (e.g. driving a car or operating machinery).</p><p>Patients should be advised to take precautions to avoid hypoglycaemia whilst driving, this is particularly important in those who have reduced or absent awareness of the warning signs of hypoglycaemia or have frequent episodes of hypoglycaemia. The advisability of driving should be considered in these circumstances.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Summary of safety profile</u></p><p>Hypoglycaemia is the most frequent undesirable effect of insulin therapy that a patient with diabetes may suffer. Severe hypoglycaemia may lead to loss of consciousness, and in extreme cases, death. No specific frequency for hypoglycaemia is presented, since hypoglycaemia is a result of both the insulin dose and other factors e.g. a patient`s level of diet and exercise.</p><p><u>Tabulated list of adverse reactions</u></p><p>The following related adverse reactions from clinical trials are listed below as MedDRA preferred term by system organ class and in order of decreasing incidence (very common: &ge;1/10; common: &ge;1/100 to &lt;1/10; uncommon: &ge;1/1,000 to &lt;1/100; rare: &ge;1/10,000 to &lt;1/1,000; very rare: &lt;1/10,000); not known (cannot be estimated form the available data).</p><p>Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.</p><table border="1" cellspacing="0" cellpadding="0" style="width:557px"><tbody><tr><td style="vertical-align:top"><p><strong>MedDRA system organ classes</strong></p></td><td style="vertical-align:top"><p><strong>Very common</strong></p></td><td style="vertical-align:top"><p><strong>Common</strong></p></td><td style="vertical-align:top"><p><strong>Uncommon</strong></p></td><td style="vertical-align:top"><p><strong>Rare</strong></p></td><td style="vertical-align:top; width:55px"><p><strong>Very rare</strong></p></td><td style="vertical-align:top; width:53px">Not known</td></tr><tr><td colspan="6" style="vertical-align:top; width:502px"><p><strong>Immune system disorders </strong></p></td><td style="vertical-align:top; width:53px">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Local allergy</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>X</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top; width:55px"><p>&nbsp;</p></td><td style="vertical-align:top; width:53px">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Systemic allergy</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>X</p></td><td style="vertical-align:top; width:55px"><p>&nbsp;</p></td><td style="vertical-align:top; width:53px">&nbsp;</td></tr><tr><td colspan="6" style="vertical-align:top; width:502px"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td><td style="vertical-align:top; width:53px">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Lipodystrophy</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>X</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top; width:55px"><p>&nbsp;</p></td><td style="vertical-align:top; width:53px">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp; &nbsp;Cutaneous amyloidosis</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top; width:55px">&nbsp;</td><td style="vertical-align:top; width:53px">&nbsp; &nbsp; X</td></tr></tbody></table><p><strong>&nbsp;</strong><u>Description of selected adverse reactions</u></p><p><em>Local allergy </em></p><p>Local allergy in patients is common Redness, swelling, and itching can occur at the site of insulin injection. This condition usually resolves in a few days to a few weeks. In some instances, this condition may be related to factors other than insulin, such as irritants in the skin cleansing agent or poor injection technique.</p><p><em>Systemic allergy</em></p><p>Systemic allergy,&nbsp; which is rare but potentially more serious, is a generalised allergy to insulin. It may cause a rash over the whole body, shortness of breath, wheezing, reduction in blood pressure, fast pulse, or sweating. Severe cases of generalised allergy may be life-threatening.</p><p><em>Skin and subcutaneous tissue disorders:</em></p><p>Lipodystrophy and cutaneous amyloidosis may occur at the injection site and delay local insulin absorption. Continuous rotation of the injection site within the given injection area may help to reduce or prevent these reactions (See section 4.4).</p><p><em>Oedema</em></p><p>Cases of oedema have been reported with insulin therapy, particularly if previous poor metabolic control is improved by intensified insulin therapy.</p><p><strong><em>&nbsp;</em></strong><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed below.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>To report any side effect(s):</strong></p><p>-The National Pharmacovigilance Centre (NPC):</p><p>o&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>o&nbsp;&nbsp; SFDA Call Center: 19999</p><p>o&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>o&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Insulins have no specific overdose definitions because serum glucose concentrations are a result of complex interactions between insulin levels, glucose availability and other metabolic processes. Hypoglycaemia may occur as a result of an excess of insulin activity relative to food intake and energy expenditure.</p><p>Hypoglycaemia may be associated with listlessness, confusion, palpitations, headache, sweating and vomiting.</p><p>Mild hypoglycaemic episodes will respond to oral administration of glucose or other sugar or saccharated products.</p><p>Correction of moderately severe hypoglycaemia can be accomplished by intramuscular or subcutaneous administration of glucagon, followed by oral carbohydrate when the patient recovers sufficiently. Patients who fail to respond to glucagon must be given glucose solution intravenously.</p><p>If the patient is comatose, glucagon should be administered intramuscularly or subcutaneously. However, glucose solution must be given intravenously if glucagon is not available or if the patient fails to respond to glucagon. The patient should be given a meal as soon as consciousness is recovered.</p><p>Sustained carbohydrate intake and observation may be necessary because hypoglycaemia may recur after apparent clinical recovery.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group : Drugs used in diabetes, insulins and analogues for injection, &nbsp;fast-acting,ATC code: A10A B04</p><p>The primary activity of insulin lispro is the regulation of glucose metabolism.</p><p>In addition, insulins have several anabolic and anti-catabolic actions on a variety of different tissues. Within muscle tissue this includes increasing glycogen, fatty acid, glycerol and protein synthesis and amino acid uptake, while decreasing glycogenolysis, gluconeogenesis, ketogenesis, lipolysis, protein catabolism and amino acid output.</p><p>Insulin lispro has a rapid onset of action (approximately 15&nbsp;minutes), thus allowing it to be given closer to a meal (within zero to 15 minutes of the meal) when compared to soluble insulin (30 to 45&nbsp;minutes before). Insulin lispro takes effect rapidly and has a shorter duration of activity (2 to 5&nbsp;hours) when compared to soluble insulin.</p><p>Clinical trials in patients with type 1 and type 2 diabetes have demonstrated reduced postprandial<u> </u>hyperglycaemia with insulin lispro compared to soluble human insulin.<!--[if gte mso 9]><xml>
  <o:OLEObject Type="Embed" ProgID="Word.Picture.8" ShapeID="_x0000_s1026"
   DrawAspect="Content" ObjectID="_1654857242">
  </o:OLEObject>
 </xml><![endif]--><br />&nbsp;As with all insulin preparations, the time course of insulin lispro action may vary in different individuals or at different times in the same individual and is dependent on dose, site of injection, blood supply, temperature and physical activity. The typical activity profile following subcutaneous injection is illustrated below.</p><p><img alt="" width="1152" height="648" src="data:image/png;base64,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" /></p><p>The above representation reflects the relative amount of glucose over time required to maintain the subject&#39;s whole blood glucose concentrations near fasting levels and is an indicator of the effect of these insulins on glucose metabolism over time.</p><p>Clinical trials have been performed in children (61 patients aged 2 to 11) and children and adolescents (481 patients aged 9 to 19 years), comparing insulin lispro to human soluble insulin. The pharmacodynamic profile of insulin lispro in children is similar to that seen in adults.</p><p>When used in subcutaneous infusion pumps, treatment with insulin lispro has been shown to result in lower glycosylated haemoglobin levels compared to soluble insulin.&nbsp; In a double-blind, crossover study, the reduction in glycosylated haemoglobin levels after 12 weeks dosing was 0.37 percentage points with insulin lispro, compared to 0.03 percentage points for soluble insulin (p&nbsp;=&nbsp;0.004).</p><p>In patients with type 2 diabetes on maximum doses of sulphonyl urea agents, studies have shown that the addition of insulin lispro significantly reduces HbA<sub>1c</sub> compared to sulphonyl urea alone. The reduction of HbA<sub>1c</sub> would also be expected with other insulin products e.g. soluble or isophane insulins.</p><p>Clinical trials in patients with type 1 and type 2 diabetes have demonstrated a reduced number of episodes of nocturnal hypoglycaemia with insulin lispro compared to soluble human insulin. In some studies, reduction of nocturnal hypoglycaemia was associated with increased episodes of daytime hypoglycaemia.</p><p>The glucodynamic response to insulin lispro is not affected by renal or hepatic function impairment. Glucodynamic differences between insulin lispro and soluble human insulin, as measured during a glucose clamp procedure, were maintained over a wide range of renal function.</p><p><strong>&nbsp;</strong>Insulin lispro has been shown to be equipotent to human insulin on a molar basis but its effect is more rapid and of a shorter duration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The pharmacokinetics of insulin lispro reflect a compound that is rapidly absorbed, and achieves peak blood levels 30 to 70&nbsp;minutes following subcutaneous injection. When considering the clinical relevance of these kinetics, it is more appropriate to examine the glucose utilisation curves (as discussed in 5.1).</p><p>Insulin lispro maintains more rapid absorption when compared to soluble human insulin in patients with renal impairment. In patients with type 2 diabetes over a wide range of renal function the pharmacokinetic differences between insulin lispro and soluble human insulin were generally maintained and shown to be independent of renal function.&nbsp; Insulin lispro maintains more rapid absorption and elimination when compared to soluble human insulin in patients with hepatic impairment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In <em>in vitro</em> tests, including binding to insulin receptor sites and effects on growing cells, insulin lispro behaved in a manner that closely resembled human insulin. Studies also demonstrate that the dissociation of binding to the insulin receptor of insulin lispro is equivalent to human insulin. Acute, one month and twelve month toxicology studies produced no significant toxicity findings.</p><p>Insulin lispro did not induce fertility impairment, embryotoxicity or teratogenicity in animal studies.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>m-</em>Cresol</p><p>Glycerol</p><p>Dibasic sodium phosphate.&nbsp;7H2O</p><p>Zinc oxide</p><p>Water for injections</p><p>Hydrochloric acid and sodium hydroxide maybe used to adjust pH.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Vial</u></p><p>This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Before use
3 years. 
After first use
28 days.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not freeze. Do not expose to excessive heat or direct sunlight.</p><p><u>Before use</u></p><p>Store in a refrigerator (2&deg;C - 8&deg;C).</p><p><u>After first use</u></p><p><em><u>Vial</u></em></p><p>Store in a refrigerator (2&deg;C &ndash; 8&deg;C) or below 30&deg;C.</p><p>&nbsp;</p><p>.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Vial</u></p><p>The solution is contained in type I flint glass vials, sealed with butyl or halobutyl stoppers and secured with aluminium seals. Dimeticone or silicone emulsion may be used to treat the vial stoppers.</p><p>10&nbsp;ml vial: Packs of 1 or 2 or a multipack of 5 (5 packs of 1). Not all packs may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Instructions for use and handling</u></p><p>To prevent the possible transmission of disease, each cartridge or pen must be used by one patient only, even if the needle on the delivery device is changed.&nbsp; Patients using vials must never share needles or syringes. The patient should discard the needle after every injection.</p><p>The Humalog solution should be clear and colourless. Humalog should not be used if it appears cloudy, thickened, or slightly coloured or if solid particles are visible.</p><p>Do not mix insulin in vials with insulin in cartridges. See section 6.2.</p><p><em>Preparing a dose</em></p><p>Vial</p><p>The vial is to be used in conjunction with an appropriate syringe (100&nbsp;unit markings).</p><p>i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Humalog</u></p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wash your hands.</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If using a new vial, flip off the plastic protective cap, but <strong>do not</strong> remove the stopper.&nbsp;</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If the therapeutic regimen requires the injection of basal insulin and Humalog at the same time, the two can be mixed in the syringe. If mixing insulins, refer to the instructions for mixing that follow in Section (ii) and 6.2.</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Draw air into the syringe equal to the prescribed Humalog dose. Wipe the top of the vial with a swab. Put the needle through the rubber top of the Humalog vial and inject the air into the vial.</p><p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turn the vial and syringe upside down. Hold the vial and syringe firmly in one hand.</p><p>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Making sure the tip of the needle is in the Humalog, withdraw the correct dose into the syringe.</p><p>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Before removing the needle from the vial, check the syringe for air bubbles that reduce the amount of Humalog in it. If bubbles are present, hold the syringe straight up and tap its side until the bubbles float to the top. Push them out with the plunger and withdraw the correct dose.</p><p>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove the needle from the vial and lay the syringe down so that the needle does not touch anything.</p><p>ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Mixing Humalog with longer-acting Human Insulins (see section 6.2)</u></p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Humalog should be mixed with longer-acting human insulins only on the advice of a doctor.</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Draw air into the syringe equal to the amount of longer-acting insulin being taken. Insert the needle into the longer-acting insulin vial and inject the air. Withdraw the needle.</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Now inject air into the Humalog vial in the same manner, but <strong>do not</strong> withdraw the needle.</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turn the vial and syringe upside down.</p><p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Making sure the tip of the needle is in the Humalog, withdraw the correct dose of Humalog into the syringe.</p><p>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Before removing the needle from the vial, check the syringe for air bubbles that reduce the amount of Humalog in it. If bubbles are present, hold the syringe straight up and tap its side until the bubbles float to the top. Push them out with the plunger and withdraw the correct dose.</p><p>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove the needle from the vial of Humalog and insert it into the vial of the longer-acting insulin. Turn the vial and syringe upside down. Hold the vial and syringe firmly in one hand and shake gently. Making sure the tip of the needle is in the insulin, withdraw the dose of longer-acting insulin.</p><p>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdraw the needle and lay the syringe down so that the needle does not touch anything.</p><p><em>Injecting a dose</em></p><p>If using a pre-filled or reusable pen refer to the detailed instructions for preparing the pen and injecting the dose, the following is a general description.</p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wash your hands</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Choose a site for injection.</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clean the skin as instructed.</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stabilise the skin by spreading it or pinching up a large area. Insert the needle and inject as instructed.</p><p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pull the needle out and apply gentle pressure over the injection site for several seconds. Do not rub the area.</p><p>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dispose of the syringe and needle safely. For an injection device use the outer needle cap, unscrew the needle and dispose of it safely.</p><p>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use of the injection sites should be rotated so that the same is not used more than approximately once a month.</p><p>Any unused product or waste material should be disposed of in accordance with local requirements.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Eli Lilly and Company, Indianapolis, IN. 46285. United States.



            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 September 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>